BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3040% above fair value

$72.80−0.02 (-0.03%)

Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%

Bio-Techne pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Bio-Techne's pe ratio was 62.8× on Nov 11, 2026, against 131.7× a year earlier. Over the last 5 years it ranged from 31.0× to 136.0×, with a median of 62.7×.

PE Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	62.8×	−57.3
2025	Dec 31, 2025	120.0×	+43.4
2024	Dec 31, 2024	76.6×	+25.9
2023	Dec 29, 2023	50.8×	+4.5
2022	Dec 30, 2022	46.3×	−73.4
2021	Dec 31, 2021	119.8×	+68.9
2020	Dec 31, 2020	50.8×	−41.0
2019	Dec 31, 2019	91.8×	+48.4
2018	Dec 31, 2018	43.5×	−23.0
2017	Dec 29, 2017	66.4×	+28.2
2016	Dec 30, 2016	38.2×	+6.9
2015	Dec 31, 2015	31.4×	−0.6
2014	Dec 31, 2014	32.0×	+1.3
2013	Dec 31, 2013	30.6×	+7.7
2012	Dec 31, 2012	22.9×	+0.6
2011	Dec 30, 2011	22.4×	−0.1
2010	Dec 31, 2010	22.5×	−2.2
2009	Dec 31, 2009	24.7×	–